← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
26	26 Caribou Biosciences CRBU $48.2M	120	+16	+15%	$203M
27	27 Precision BioSciences DTIL $167M	119	-33	-22%	$93.5M
28	28 Sana Biotechnology SANA $730M	116	-1	-0.9%	$808M
29	ATHX 29 DELISTED Athersys, Inc. Common Stock ATHX	115	-10	-8%	$10.9M
30	30 Nkarta NKTX $143M	115	+31	+37%	$537M
31	31 MeiraGTx Holdings MGTX $933M	108	+5	+5%	$216M
32	32 Adicet Bio ACET $47.3M	101	+14	+16%	$556M
33	33 Lineage Cell Therapeutics LCTX $241M	101	-9	-8%	$103M
34	34 Instil Bio TIL $42.8M	98	+20	+26%	$551M
35	35 Cartesian Therapeutics RNAC $199M	92	-10	-10%	$79.7M
36	36 DELISTED Generation Bio GBIO	91	+3	+3%	$364M
37	37 4D Molecular Therapeutics FDMT $686M	89	+9	+11%	$182M
38	38 Passage Bio PASG $12.5M	85	-23	-21%	$99.6M
39	TCRR 39 DELISTED TCR2 Therapeutics Inc. Common Stock TCRR	83	-11	-12%	$72.2M
40	40 Lakefront Biotherapeutics American Depositary Shares LKFT $1.97B	81	-8	-9%	$720M
41	41 Voyager Therapeutics VYGR $127M	78	+8	+11%	$142M
42	ADAP 42 DELISTED Adaptimmune Therapeutics ADAP	77	-3	-4%	$195M
43	43 DELISTED Adverum Biotechnologies ADVM	77	-15	-16%	$70M
44	ATNX 44 DELISTED Athenex, Inc. Common Stock ATNX	76	-15	-16%	$14.7M
45	45 Lyell Immunopharma LYEL $193M	75	-4	-5%	$689M
46	46 DELISTED Carisma Therapeutics CARM	73	-11	-13%	$23.1M
47	RUBY 47 DELISTED Rubius Therapeutics, Inc RUBY	72	-45	-38%	$66.6M
48	48 Mustang Bio MBIO $2.91M	71	-10	-12%	$10.3M
49	49 DELISTED Arcellx ACLX	68	+19	+39%	$622M
50	50 Autolus Therapeutics AUTL $458M	67	0	0%	$144M